Professional Documents
Culture Documents
Report
Course Medpharma lab - Medpharma laboratory
Lesson Airways Resistance – Lab
Student email kibtabungar2019@plm.edu.ph
Group Activity
Asthma – Challenge
The schematic below shows the ligands, receptors, and pathways that produce the symptoms of asthma: constriction of
bronchial smooth muscle and mucus secretion. Place the labels to indicate where the following drugs act to reduce the
symptoms of asthma.
Salbutamol
(a selective agonist)
Ipratroprium
(an antagonist)
Theophylline
(a methylxanthine)
Force transducer setup
Force
Time
What volume (in mL) of a 6 × 10-5 M stock solution would be required to give a nal concentration of 3 × 10-6 M in a 30
mL organ bath?
1.5 µL
1.5 mL
600 µL
Known variables
You already know the volume of your organ bath. Add to the table the concentration of the provided stock solutions.
Organ Bath Volume (mL) Histamine Stock Solution (M) Salbutamol Stock Solution (M)
The doses of histamine and salbutamol you will add to the organ bath:
Final Bath Concentration (M) Dose of Histamine to Add (µL) Dose of Salbutamol to Add (µL)
Organ Bath Volume (mL) Acetylcholine Stock Solution (M) Ipratropium Stock Solution (M)
Final Bath Concentration (M) Dose of Acetylcholine to Add (µL) Dose of Ipratropium to Add (µL)
What do you predict will be the response of the trachea to histamine application, then salbutamol application?
Histamine induces bronchoconstriction then the addition of salbutamol will inhibit the bronchial responsiveness to
histamine, producing bronchodilation.
Final Bath Concentration (M) Force with Histamine (mN) Force with Salbutamol (mN)
1e-8
3e-8
1e-7
3e-7
1e-6
3e-6
1e-5
3e-5
1e-4
Untitled Graph
Incomplete data in table
Unlabeled Axis
Unlabeled Axis
Force with Histamine (mN) Force with Salbutamol (mN)
What were the observed responses to the application of histamine, and then salbutamol?
Were your results di erent from your prediction? If so, how were they di erent?
Binds β2 receptors
Phospholipase C activated
What do you predict will be the response of the trachea to acetylcholine application, and then ipratropium?
Final Bath Concentration (M) Force with Acetylcholine (mN) Force with Ipratropium (mN)
1e-8
3e-8
1e-7
3e-7
1e-6
3e-6
1e-5
3e-5
1e-4
Acetylcholine EC50
Ipratropium IC50
Untitled Graph
Incomplete data in table
Unlabeled Axis
Unlabeled Axis
Force with Acetylcholine (mN) Force with Ipratropium (mN)
What were the observed responses of the tissue to acetylcholine application, and then ipratropium?
Were your results di erent from your prediction? If so, how were they di erent?
Describe the mechanism by which acetylcholine causes bronchial contraction, and also the mechanism by which
ipratropium causes bronchial relaxation.
Acetylcholine will bind to m3 receptors, activating the Gq subunit of the G protein. Phospolipase C will then be
activated, converting PIP2 to IP3 and DAG. These will then increase intracellular calcium and therefore cause
bronchoconstriction. Ipratropium acts as an antagonist of the muscarinic acetylcholine receptor. This e ect produces
the inhibition of the parasympathetic nervous system in the airways and hence, inhibit their function. The function of
the parasympathetic system in the airway is to generate bronchial secretions and constriction and hence, the inhibition
of this action can lead to bronchodilation and fewer secretions.
Theophylline – Activity
What do you predict will be the response of the trachea to salbutamol following histamine and theophylline application?
Theophylline further enhance the bronchodilatory e ect that was already imposed by the salbutamol.
Final Bath Concentration (M) Organ Bath Volume (mL) Theophylline Stock Solution (M) Dose to Add (µL)
Theophylline – Analysis
Final Bath Concentration (M) Force with Histamine (mN) Force with Salbutamol in the Presence of
Theophylline (mN)
1e-8
3e-8
1e-7
3e-7
1e-6
3e-6
1e-5
3e-5
1e-4
Untitled Graph
Incomplete data in table
Unlabeled Axis
Unlabeled Axis
Force with Histamine (mN) Force with Salbutamol in the Presence of Theophylline (mN)
What was the response of the trachea when theophylline was present with salbutamol and histamine?
Were your results di erent from your prediction? If so, how were they di erent?
An interaction between two or more drugs that causes the total e ect of the drugs to be greater than the sum of the
individual e ects of each drug. A synergistic e ect can be bene cial or harmful.
Describe the mechanisms of how salbutamol and theophylline act to reduce contraction strength in the trachea. Explain
how they compliment each other to act in a synergistic way.
On a cellular level, it is known that theophylline inhibits mediator release from mast cells by decreasing destruction of
cyclic adenosine monophosphate whereas salbutamol binds to beta2 adrenergic receptors which increases CAMP that
leads to decreased intracellular calcium. Ultimately, both theophylline and salbutamol cause increased CAMP levels.
Therefore, the interaction of these two drugs might be explained ultimately on a cellular level by their ability to a ect
mediator release by acting on di erent biochemical pathways.
Summary
Describe in everyday language how salbutamol is used to treat acute asthma symptoms.
During acute asthma attacks, the airways are narrowed and lled with mucus that it is di cult for air to move in and
out. Salbutamol, usually given through an inhaler, o ers quick relief during acute asthma attacks by relaxing the
muscles of our airways and therefore helps us breathe more easily.
Popup - Notebook
Re ection notebook:
Organ Bath Volume (mL) Histamine Stock Solution (M) Salbutamol Stock Solution (M)
Organ Bath Volume (mL) Acetylcholine Stock Solution (M) Ipratropium Stock Solution (M)